Peptidakzeptorbindungsverfahren

European patent · EP1870417 · Deleted

Register entry

Publication number
EP1870417
Application number
EP07005917
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 19, 2000
Published
Dec 26, 2007
Granted
Mar 28, 2012
Deleted
Jul 18, 2020
Reason
Maximum term reached
IPC classes
C07K 1/107 (2006.01)
C07K 17/02 (2006.01)
C12P 19/34 (2006.01)
C12N 15/11 (2006.01)
C12N 15/10 (2006.01)
Priority
US 145834 P 27.07.1999
Divided from
EP00947524
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 20, 2020

    Maximum term reached

    Published in Swissreg on 20.07.2020

  2. May 15, 2012

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 15.05.2012

  3. Mar 28, 2012

    Granted

    Published in Swissreg on 28.03.2012

Parties

Holder

Bristol-Myers Squibb Company

Route 206 and Province Line Road, Princeton, NJ 08543-4000, US

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

Kurz, Markus

4054 Basel

Lohse, Peter

Weston, MA 02493, US

Wagner, Richard

Cambridge, MA 02138, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.